Granulomatosis with polyangiitis: Difference between revisions
(#REDIRECT Wegener granulomatosis) |
No edit summary |
||
| Line 1: | Line 1: | ||
# | __NOTOC__ | ||
{{DiseaseDisorder infobox | | |||
Name = Wegener's granulomatosis | | |||
Image = Wegner's-granulomatosis-001.jpg| | |||
Caption = | | |||
ICD10 = {{ICD10|M|31|3|m|30}} | | |||
ICD9 = {{ICD9|446.4}} | | |||
ICDO = | | |||
OMIM = | | |||
DiseasesDB = 14057 | | |||
MedlinePlus = 000135 | | |||
eMedicineSubj = | | |||
eMedicineTopic = | | |||
MeshID = D014890 | | |||
}} | |||
{{Wegener's granulomatosis}} | |||
'''For patient information click [[Wegener's granulomatosis (patient information)|here]]''' | |||
'''Click [[The Heart in Wegener's Granulomatosis|here]] for The heart in Wegener's granulomatosis''' | |||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | |||
==[[Wegener's granulomatosis overview|Overview]]== | |||
==[[Wegener's granulomatosis historical perspective|Historical Perspective]]== | |||
==[[Wegener's granulomatosis pathophysiology|Pathophysiology]]== | |||
==[[Wegener's granulomatosis causes|Causes]]== | |||
==[[Wegener's granulomatosis differential diagnosis|Differentiating Wegener's granulomatosis from other Diseases]]== | |||
==[[Wegener's granulomatosis epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Wegener's granulomatosis risk factors|Risk Factors]]== | |||
==[[Wegener's granulomatosis screening|Screening]]== | |||
==[[Wegener's granulomatosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
== Diagnosis == | |||
[[Wegener's granulomatosis history and symptoms| History and Symptoms]] | [[Wegener's granulomatosis physical examination | Physical Examination]] | [[Wegener's granulomatosis laboratory findings| Laboratory Findings]] | [[Wegener's granulomatosis diagnostic criteria|Diagnostic criteria]] | [[Wegener's granulomatosis chest X ray|Chest X Ray]] | [[Wegener's granulomatosis CT|CT]] | [[Wegener's granulomatosis other diagnostic studies|Other diagnostic studies]] | |||
==Treatment== | |||
[[Wegener's granulomatosis medical therapy|Medical therapy]] | [[Wegener's granulomatosis surgery|Surgery]] | [[Wegener's granulomatosis primary prevention|Primary prevention]] | [[Wegener's granulomatosis secondary prevention|Secondary prevention]] | [[Wegener's granulomatosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Wegener's granulomatosis future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Wegener's granulomatosis case study one|Case #1]] | |||
[[fr:Granulomatose de Wegener]] | |||
[[ja:ウェゲナー肉芽腫症]] | |||
[[pt:Granulomatose de Wegener]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Arthritis]] | |||
[[Category:Diseases involving the fasciae]] | |||
[[Category:Rheumatology]] | |||
[[Category:Nephrology]] | |||
[[Category:Pulmonology]] | |||
[[Category:Autoimmune diseases]] | |||
Revision as of 19:00, 28 September 2012
Template:DiseaseDisorder infobox
|
Granulomatosis with polyangiitis Microchapters |
|
Differentiating Granulomatosis with polyangiitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Granulomatosis with polyangiitis On the Web |
|
American Roentgen Ray Society Images of Granulomatosis with polyangiitis |
|
Directions to Hospitals Treating Granulomatosis with polyangiitis |
|
Risk calculators and risk factors for Granulomatosis with polyangiitis |
For patient information click here
Click here for The heart in Wegener's granulomatosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Wegener's granulomatosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Diagnostic criteria | Chest X Ray | CT | Other diagnostic studies
Treatment
Medical therapy | Surgery | Primary prevention | Secondary prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies